• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效通用佐剂系统,适用于孤儿药或与贫困相关的疫苗。

Highly effective generic adjuvant systems for orphan or poverty-related vaccines.

机构信息

Division of Retrovirology, U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 1600 East Gude Drive, Rockville, MD 20850, USA.

出版信息

Vaccine. 2011 Jan 29;29(5):873-7. doi: 10.1016/j.vaccine.2010.11.049. Epub 2010 Nov 27.

DOI:10.1016/j.vaccine.2010.11.049
PMID:21115053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4190060/
Abstract

Safe and effective adjuvants are needed for many vaccines with limited commercial appeal, such as vaccines to infrequent (orphan) diseases or to neglected and poverty-related diseases. Here we found that three nonproprietary liposome formulations containing monophosphoryl lipid A each induced 3-fold to 5-fold increased titers of binding and neutralizing antibodies to anthrax protective antigen compared to aluminum hydroxide-adsorbed antigen in monkeys. All vaccinated monkeys were protected against lethal challenge with aerosolized Ames strain spores.

摘要

安全有效的佐剂对于许多商业吸引力有限的疫苗是必需的,例如针对罕见(孤儿)疾病或被忽视和贫困相关疾病的疫苗。在这里,我们发现三种非专利脂质体制剂,每种制剂均含有单磷酰脂质 A,与吸附于氢氧化铝的抗原相比,能使猴体内炭疽保护性抗原的结合抗体和中和抗体滴度分别提高 3 倍至 5 倍。所有接种疫苗的猴子均能抵御雾化安姆斯株孢子的致死性攻击。

相似文献

1
Highly effective generic adjuvant systems for orphan or poverty-related vaccines.高效通用佐剂系统,适用于孤儿药或与贫困相关的疫苗。
Vaccine. 2011 Jan 29;29(5):873-7. doi: 10.1016/j.vaccine.2010.11.049. Epub 2010 Nov 27.
2
Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.炭疽疫苗抗原-佐剂配方能完全保护新西兰白兔免受炭疽杆菌埃姆斯菌株孢子的攻击。
Clin Vaccine Immunol. 2012 Jan;19(1):11-6. doi: 10.1128/CVI.05376-11. Epub 2011 Nov 16.
3
Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.用吸附炭疽疫苗对恒河猴进行接种可产生血清抗体反应,该反应在体外能有效中和与受体结合的保护性抗原。
Clin Vaccine Immunol. 2010 Nov;17(11):1753-62. doi: 10.1128/CVI.00174-10. Epub 2010 Aug 25.
4
Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.吸附于氢氧化铝佐剂的炭疽重组保护性抗原的结构与免疫学分析
Clin Vaccine Immunol. 2012 Sep;19(9):1465-73. doi: 10.1128/CVI.00174-12. Epub 2012 Jul 18.
5
Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.使用佐剂的靶向表位肽免疫原可保护兔子免受实验性吸入性炭疽感染。
Vaccine. 2015 Jan 9;33(3):430-6. doi: 10.1016/j.vaccine.2014.11.042. Epub 2014 Nov 30.
6
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.用新型纳米乳剂重组炭疽保护性抗原疫苗进行黏膜免疫可抵御炭疽芽孢杆菌孢子攻击。
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.
7
Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.灭活但代谢活跃的炭疽芽孢杆菌疫苗可诱导针对炭疽的广泛保护性免疫。
Infect Immun. 2009 Apr;77(4):1649-63. doi: 10.1128/IAI.00530-08. Epub 2009 Jan 21.
8
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.一种用于炭疽保护性抗原的CpG-聚蔗糖纳米颗粒佐剂可增强免疫原性,并为猴子提供针对吸入性炭疽的单次免疫保护。
J Immunol. 2016 Jan 1;196(1):284-97. doi: 10.4049/jimmunol.1501903. Epub 2015 Nov 25.
9
Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.经 CIA06B 佐剂增强的炭疽疫苗在免疫小鼠中对炭疽保护性抗原产生长效免疫。
Arch Pharm Res. 2013 Apr;36(4):464-71. doi: 10.1007/s12272-013-0034-5. Epub 2013 Feb 26.
10
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.确定重组炭疽疫苗在兔体内的血清学保护相关指标。
Vaccine. 2004 Jan 2;22(3-4):422-30. doi: 10.1016/j.vaccine.2003.07.004.

引用本文的文献

1
Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design Platform.T4 噬菌体作为一种基于蛋白质的、无佐剂和无针的黏膜大流行疫苗设计平台。
Annu Rev Virol. 2024 Sep;11(1):395-420. doi: 10.1146/annurev-virology-111821-111145. Epub 2024 Aug 30.
2
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.基于噬菌体的、高效、无针和无佐剂的黏膜 COVID-19 疫苗。
mBio. 2022 Aug 30;13(4):e0182222. doi: 10.1128/mbio.01822-22. Epub 2022 Jul 28.
3
Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen.定点诱变和佐剂在炭疽保护性抗原稳定性和效力中的作用
Saudi Pharm J. 2022 May;30(5):595-604. doi: 10.1016/j.jsps.2022.02.011. Epub 2022 Feb 25.
4
Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc Mice.气溶胶气管内接种重组保护性抗原(rPA)疫苗可预防 B10.D2-Hc 小鼠吸入性炭疽。
Front Immunol. 2022 Jan 26;13:819089. doi: 10.3389/fimmu.2022.819089. eCollection 2022.
5
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.一种通过CRISPR工程设计多重SARS-CoV-2候选疫苗的通用噬菌体T4纳米颗粒平台。
Sci Adv. 2021 Sep 10;7(37):eabh1547. doi: 10.1126/sciadv.abh1547. Epub 2021 Sep 8.
6
Prophylactic vaccine delivery systems against epidemic infectious diseases.针对流行性传染病的预防性疫苗投递系统。
Adv Drug Deliv Rev. 2021 Sep;176:113867. doi: 10.1016/j.addr.2021.113867. Epub 2021 Jul 17.
7
Liposome Formulations as Adjuvants for Vaccines.脂质体配方作为疫苗佐剂。
Curr Top Microbiol Immunol. 2021;433:1-28. doi: 10.1007/82_2020_227.
8
Army Liposome Formulation (ALF) family of vaccine adjuvants.陆军脂质体配方(ALF)疫苗佐剂家族。
Expert Rev Vaccines. 2020 Mar;19(3):279-292. doi: 10.1080/14760584.2020.1745636. Epub 2020 Mar 31.
9
Phage display as a tool for vaccine and immunotherapy development.噬菌体展示作为疫苗和免疫疗法开发的一种工具。
Bioeng Transl Med. 2019 Sep 18;5(1):e10142. doi: 10.1002/btm2.10142. eCollection 2020 Jan.
10
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.基于噬菌体 T4 纳米颗粒的炭疽和鼠疫双重疫苗
mBio. 2018 Oct 16;9(5):e01926-18. doi: 10.1128/mBio.01926-18.

本文引用的文献

1
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.炭疽杆菌致死因子-保护性抗原杂交抗原:生物化学、免疫原性及对兔致死性埃姆斯芽孢攻击的保护作用
Open Vaccine J. 2009;2:92-99. doi: 10.2174/1875035400902010092.
2
Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.许可的炭疽疫苗与基于电穿孔的 PA 编码 DNA 疫苗在恒河猴中的比较性能。
Vaccine. 2010 Jan 22;28(4):1056-61. doi: 10.1016/j.vaccine.2009.10.111. Epub 2009 Nov 5.
3
Advances in the development of next-generation anthrax vaccines.下一代炭疽疫苗的研发进展。
Vaccine. 2009 Nov 5;27 Suppl 4:D28-32. doi: 10.1016/j.vaccine.2009.08.102.
4
Structure of the small outer capsid protein, Soc: a clamp for stabilizing capsids of T4-like phages.小外壳蛋白 Soc 的结构:T4 样噬菌体衣壳稳定的夹具。
J Mol Biol. 2010 Jan 29;395(4):728-41. doi: 10.1016/j.jmb.2009.10.007. Epub 2009 Oct 14.
5
Boosting vaccine power.增强疫苗效力。
Sci Am. 2009 Oct;301(4):72-9. doi: 10.1038/scientificamerican1009-72.
6
Anthrax vaccination strategies.炭疽疫苗接种策略。
Mol Aspects Med. 2009 Dec;30(6):490-502. doi: 10.1016/j.mam.2009.08.006. Epub 2009 Sep 1.
7
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.埃博拉疫苗保护性免疫的相关因素:动物法则对监管审批的影响
Nat Rev Microbiol. 2009 May;7(5):393-400. doi: 10.1038/nrmicro2129.
8
Vaccine adjuvants: scientific challenges and strategic initiatives.疫苗佐剂:科学挑战与战略举措
Expert Rev Vaccines. 2009 Mar;8(3):293-8. doi: 10.1586/14760584.8.3.293.
9
New horizons in adjuvants for vaccine development.疫苗研发佐剂的新视野。
Trends Immunol. 2009 Jan;30(1):23-32. doi: 10.1016/j.it.2008.09.006. Epub 2008 Dec 6.
10
Vaccines: countering anthrax: vaccines and immunoglobulins.疫苗:对抗炭疽:疫苗与免疫球蛋白
Clin Infect Dis. 2008 Jan 1;46(1):129-36. doi: 10.1086/523578.